Skip to content

A clinical trial to see the effect of some ayurvedic formulation in the treatment of vataja pratishyaya with reference to Allergic Rhinitis.

A Randomized Controlled Trial to evaluate the efficacy of Vidangadi Taila Nasya and Shadbindu Ghrita Nasya in Vataja Pratishyaya with reference to Allergic Rhinitis. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080937
Enrollment
40
Registered
2025-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

None listed

Sponsors

Sane Guruji Arogya Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of age group 18 to 60 years, irrespective of either gender, religion and socio-economic status. 2.Patients with indications Nasya Karma. 3.All patients having signs and symptoms- Nasavrodha/Aanaddhapihita (Nasal Congestion) Tanustrava (Rhinorrhoea) Kshavathu (Sneezing)

Exclusion criteria

Exclusion criteria: 1.Pregnant women and children. 2.History of congenital disorder of Nose. 3.Patients with, Nasal Polyp, Tumours requiring surgical intervention. 4.Patients with contra-indications of Nasya Karma. Patients with Samavastha (Fever).

Design outcomes

Primary

MeasureTime frame
symptoms like 1.Nasavrodha/Aanaddhapihita (Nasal Congestion) 2.Tanustrava (Rhinorrhoea) 3.Kshavathu (Sneezing) Will be decreased and relief from Allergic Rhinitis Timepoint: follow up on 4th, 7th day , symptoms will be noted before and after the treatment

Secondary

MeasureTime frame
decrease in severity , intensity , duration of symptomsTimepoint: 18 months

Countries

India

Contacts

Public ContactProf Dr Mrs Nilakshi S Pradhan

MAMS Sumatibhai Shah Ayurved Mahavidyalaya

drnspradhan@yahoo.com9423580963

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026